Acquired hypopigmentation (leukoderma) as a presenting feature of metastatic amelanotic melanoma with brain involvement. [electronic resource]
- Archives of neurology Dec 2007
- 1786-7 p. digital
Publication Type: Case Reports; Journal Article
0003-9942
10.1001/archneur.64.12.1786 doi
Anti-Inflammatory Agents--therapeutic use Antineoplastic Agents, Alkylating--therapeutic use Brain--pathology Brain Neoplasms--pathology Dacarbazine--analogs & derivatives Dexamethasone--therapeutic use Humans Hypopigmentation--etiology Immunoenzyme Techniques Magnetic Resonance Imaging Male Melanoma, Amelanotic--pathology Middle Aged Neurologic Examination Skin Neoplasms--pathology Temozolomide